Novo Nordisk
(NYSE:NVO)
$122.13
-0.62[-0.51%]
At close: Apr 19
$122.13
0[0.00%]
After Hours: 7:24PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
75%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
60
0100

Novo Nordisk Stock (NYSE:NVO), Quotes and News Summary

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Open$123.480
Close$122.710
Volume / Avg.5.183M / 5.009M
Day Range122.460 - 124.540
52 Wk Range75.560 - 138.280
Market Cap$544.887B
P/E Ratio46.314
Dividend Yield1.120%
ExchangeNYSE
RSI
41
Short Interest
0.17%
Days to Cover1

Recent News

German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
Novo Nordisk's acquisition of Cardior Pharmaceuticals clears regulatory hurdles, advancing cardiovascular treatment development with CDR132L. Learn about the promising phase 2 trials and strategic expansion. Deal expected to close Q2 2024.
Vandana Singh
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
Facing a shortage, GLP-1 weight loss drugs by Eli Lilly & Novo Nordisk struggle to meet demand. Learn about supply issues and efforts to address them, impacting availability till 2025.
Vandana Singh
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
BMO's coverage of Novo Nordisk, spotlighting its groundbreaking advancements in weight loss and diabetes drugs. Analysts foresee Novo and Eli Lilly maintaining dominance in the obesity market, fueled by strong pipelines and promising trial results.
Vandana Singh
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
3
Dec 23
1
Jan
5
Feb
2
Mar
4
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Novo Nordisk
Sector
Health Care
Industry
Pharmaceuticals
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NVO
JNJ

FAQ

Q

How do I buy Novo Nordisk (NVO) stock?

A

You can purchase shares of Novo Nordisk (NYSE: NVO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Novo Nordisk's (NVO) competitors?

A

Other companies in Novo Nordisk’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).

Q

What is the target price for Novo Nordisk (NVO) stock?

A

The latest price target for Novo Nordisk (NYSE: NVO) was reported by Cantor Fitzgerald on Thursday, April 18, 2024. The analyst firm set a price target for 160.00 expecting NVO to rise to within 12 months (a possible 31.01% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Novo Nordisk (NVO)?

A

The stock price for Novo Nordisk (NYSE: NVO) is $122.13 last updated Today at April 19, 2024 at 7:24 PM EDT.

Q

Does Novo Nordisk (NVO) pay a dividend?

A

A quarterly cash dividend of $2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

Q

When is Novo Nordisk (NYSE:NVO) reporting earnings?

A

Novo Nordisk’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Novo Nordisk (NVO) going to split?

A

There is no upcoming split for Novo Nordisk.

Q

What sector and industry does Novo Nordisk (NVO) operate in?

A

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch